Litigation Details for In Re: Actos Direct Purchaser Antitrust Litigation (S.D.N.Y. 2015)
✉ Email this page to a colleague
In Re: Actos Direct Purchaser Antitrust Litigation (S.D.N.Y. 2015)
| Docket | ⤷ Try a Trial | Date Filed | 2015-04-27 |
| Court | District Court, S.D. New York | Date Terminated | |
| Cause | 15:1 Antitrust Litigation (Monopolizing Trade) | Assigned To | Ronnie Abrams |
| Jury Demand | Plaintiff | Referred To | Stewart D. Aaron |
| Patents | 6,150,383; 6,150,384; 6,166,042; 6,166,043; 6,172,090; 6,211,205; 6,271,243; 6,303,640; 6,329,404 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in In Re: Actos Direct Purchaser Antitrust Litigation
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for In Re: Actos Direct Purchaser Antitrust Litigation (S.D.N.Y. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-04-27 | 1 | Patent No. Issue Date Patent Expiry 6,150,383 (the…its patent information that the two patents—United States Patent Nos. 5,965,584 (the “’584 Patent”) and…manufacturer’s patents and patent information for accuracy or trustworthiness. In listing patents and patent information…the ’777 Patent, the ’584 Patent, and the ’404 Patent, Takeda submitted eight other patents to the FDA…the ’584 Patent and the ’404 Patent as drug product patents claiming ACTOS only if the patents in fact | External link to document | |
| 2019-10-08 | 131 | Memorandum & Opinion | two other patents-U.S. Patent Nos. 5,965,584 (the "'584 patent") and 6,329,404 (the "… several patents related to its diabetes medicines. The first of those patents, U.S. Patent. No. 4,687,777…hereinafter, "the Patents") as both drug product patents and method-of-use patents-and improperly … Normally, inventors obtain patents for their brand-name drugs. Patents that protect a drug may include…such patents must be submitted with an NDA is at the heart of this case. For each patent that | External link to document |
| 2016-01-06 | 54 | Patent No. Issue Date Patent Expiry 6,150,383 (the…listed three additional patents – the ’042 Patent, the ’043 Patent, and the ’090 Patent – as applicable method-of-use…Takeda asserted in its patent information that the two patents – United States Patent Nos. 5,965,584 (the…misleading patent information regarding the ’584 Met Combo Patent and ’404 Insulin Combo Patent for ACTOS… drug substance patent – U.S. Patent No. 4,687,777 (the “’777 ACTOS Compound Patent”) – expired on January | External link to document | |
| 2016-01-07 | 55 | Patent No. Issue Date Patent Expiry 6,150,383 (the…listed three additional patents – the ’042 Patent, the ’043 Patent, and the ’090 Patent – as applicable method-of-use…Takeda asserted in its patent information that the two patents – United States Patent Nos. 5,965,584 (the…misleading patent information regarding the ’584 Met Combo Patent and ’404 Insulin Combo Patent for ACTOS… drug substance patent – U.S. Patent No. 4,687,777 (the “’777 ACTOS Compound Patent”) – expired on January | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
